39835-08-0 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Bollettino delle Sedute della Accademia Gioenia di Scienze Naturali in Catania,1957,vol. <4> 4,p. 205,213
[2]Journal of Organic Chemistry,2001,vol. 66,p. 5866 - 5874
Reference: [1] Journal of the Society of Chemical Industry, London, 1949, vol. 68, p. 329
[2] Farmaco (1946-1952), 1948, vol. 3, p. 509,523
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 132 - 135
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 3, p. 668 - 671
[3] Patent: WO2007/38387, 2007, A2, . Location in patent: Page/Page column 24; 25
[4] Justus Liebigs Annalen der Chemie, 1912, vol. 390, p. 23
[5] Patent: US6140353, 2000, A,
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 23, p. 3856 - 3871
[2] Journal of the American Chemical Society, 1952, vol. 74, p. 2226,2235
[3] Journal of the American Chemical Society, 1952, vol. 74, p. 2226,2235
Reference: [1]Clinton; Laskowski
[Journal of the American Chemical Society, 1952, vol. 74, p. 2226,2235]
Current Patent Assignee: Sterling Drug Inc. - US2642436, 1951, A
[2]Clinton; Laskowski
[Journal of the American Chemical Society, 1952, vol. 74, p. 2226,2235]
Current Patent Assignee: Sterling Drug Inc. - US2642436, 1951, A
[3]Clinton; Laskowski
[Journal of the American Chemical Society, 1952, vol. 74, p. 2226,2235]
Current Patent Assignee: Sterling Drug Inc. - US2642436, 1951, A
Reference: [1]Journal of the American Chemical Society,1952,vol. 74,p. 2226,2235
* For details of the synthesis route, please refer to the original source to ensure accuracy.